Skip to content

Menu

Network Sub-MenuBrowse by SubjectBrowse by PublisherJoin the NetworkGet StartedSubscribeSupportContact

Search

Close

Enter Search Terms

Daniel Farraye

ID: 1b8392b3-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

FDA REGULATORY APPROVAL UPDATES

Big Molecule Watch · October 23, 2025

GENENTECH FILES FIRST PERTUZUMAB BPCIA COMPLAINT AGAINST SHANGHAI HENLIUS AND ORGANON

Big Molecule Watch · August 17, 2025

Update on Regeneron’s Supplemental BLA for EYLEA HD

Big Molecule Watch · April 29, 2025

FDA Approves Celltrion’s STEQEYMA (ustekinumab-stba)

Big Molecule Watch · January 6, 2025

European Commission Approves Samsung Bioepis and Biogen’s Aflibercept Biosimilar

Big Molecule Watch · November 27, 2024

Previous

12 3

Next

Claim This Record

Is this your profile? Upgrade to display your full biography, collected works, social connections, practice areas, and more.

Enhance Your Profile

Call us at 1-800-913-0988 or email sales@lexblog.com.

Facebook LinkedIn Twitter RSS

About LexBlog
The Field We Built
Library at LexBlog
Our Beliefs
Our Team
Contact LexBlog

Disclaimer
Editorial Policy
Terms of Service

Get Started
Publishing Solutions
Compass

Submit a Request
Support Center
System Status

Copyright © 2026, LexBlog, Inc. All Rights Reserved.

Law blog design & platform by LexBlog